Babylon Health

Person sitting down with a computer in front of them with a healthcare provider on the screen
By  Jessica Hagen 12:38 pm September 5, 2023
London-based multinational digital health firm Babylon has sold almost all of its U.K. assets to digital health company eMed Healthcare U.K., a subsidiary of U,S, company eMed, after announcing in early August that its deal to merge with Swiss tech firm MindMaze was canceled. Babylon Healthcare Services Limited, the piece of Babylon purchased by eMed and the bulk of what remained of Babylon...
Series B, funding, Zedsden
By  Tammy Lovell 09:51 am April 6, 2021
UK health tech startup Zedsen has announced a $12M (£8.7M) Series B round of funding at a $110 valuation. The London-based firm makes non-invasive sensors which use key biological signals from consumers’ bloodstreams to provide personalised health insights.  Investors include Joseph R Grano, former chairperson and CEO of UBS Financial Services Inc, Nasser Kazeminy, founder of NJK Holding and...
By  Dave Muoio 03:01 pm March 8, 2021
San Francisco-based behavioral health startup Ginger (formerly Ginger.io) has made two noteworthy additions to its advisory board: former U.S. Representative for Massachusetts Joe Kennedy III and Myrna Soto, the chief strategy and trust officer for cybersecurity company Forcepoint. "With a surge of people seeking care, and a growing shortage of those who provide it, our nation’s badly broken...
By  Dave Muoio 03:21 pm March 4, 2021
No-cost medications for patients in need. Online prescription discount platform GoodRx has partnered with the National Association of Free and Charitable Clinics (NAFC) to kick off a philanthropic program that will support patients in need with free prescriptions and care. With a target goal of more than $5 million in free medications provided during 2021, the company said that it has kick-...
By  Dave Muoio 02:56 pm August 3, 2020
Austin, Texas-based virtual and on-demand care provider Remedy announced Dr. Ronald Dixon as its chief medical officer. Dixon, formerly the head of clinical affairs at Onduo and the president and CEO of Onduo Professionals (its provider staffing group), is expected to draw on his experience to help Remedy build out its virtual chronic care treatment services. “Dr. Dixon’s experience in developing...
By  Tammy Lovell 05:43 am June 10, 2020
London-based digital firm Babylon Health has admitted that a data breach occurred that allowed a patient to access recordings of another patient’s consultation via the GP at Hand app. The app, which has more than 2.3 million UK users, allows members to book medical appointments, access a triage chatbot and have consultations with NHS doctors via smartphone video call.  A Babylon spokesperson says...
By  Dave Muoio 03:23 pm May 27, 2020
Higi, the maker of health kiosks found in retail pharmacies and groceries, has raised $30 million in a new funding round led by symptom-check chatbot service Babylon Health. The raise also included participation from Higi's prior backers, including 7Wire Ventures, Flare Capital Partners, Jumpstart Capital, Rush University Medical Center for Health and William Wrigley Jr. WHAT THEY DO Higi's...
By  Piers Ford 07:35 am April 14, 2020
Two NHS hospitals in the Midlands are the first to sign up for Babylon’s COVID-19 Care Assistant app in an effort to give coronavirus patients 24/7 access to support and monitoring services, despite the pressure the pandemic is placing on staff levels. Between them, the Royal Wolverhampton NHS trust and University Hospitals Birmingham NHS trust serve nearly 4.2 million people – 7.5% of England’s...
By  Dave Muoio 01:53 pm December 18, 2019
Babylon Health is lining up strategic partners as it targets January 2020 for the US launch of its triage chatbot service, according to comments from the company’s US lead that were later confirmed to MobiHealthNews by a spokesperson. Kurt Blasena, Babylon’s senior managing director of commercial strategy and revenue growth, said that the London-based company has already secured two “very large”...
By  Dave Muoio 03:38 pm April 18, 2019
Door closes on drug discovery. IBM is tapering off sales of its Watson for Drug Discovery product in favor of other healthcare offerings using the AI technology, STAT reported this morning. The decision was made in response to weak demand and purchases from customers. "We are focusing our resources within Watson Health to double down on the adjacent field of clinical development where we see an...